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The sodium pump or Na,K-ATPase, maintains the Na ÷ and K" gradients across eukaryotic cell membranes at the expense of ATP. Incubation 
of purified canine renal Na,K-ATPase with 4-acetamido-4'-isothioeyanatostilbene.2,2'-disulfoni¢ ac d (SITS) inhibited tile ATPase activity. Both 
the labeling of the protein and the loss of ATPase acti~,ity were prevented by co-incubation with ADP (acting as an ATP analog) or KCI, Only 
the a-subunit was labeled by SITS, The ~t.subunit f 'om ll~e inhibited ellzymc was extensively digested with trypsin, and SITS-labeled peptides were 
purified by reverse-phase HPLC and sequenced. The amino ~tcid sequence determined, His-Leu-Leu-Val-Met-X-Gly-Ala-Pro-Glu, indicated tlmt 
SITS modifies Lys-501 (X) on the ct-subunit of Na,K-ATPase. 
Na,K-ATPase; Enzyme inactivation; Active transport; Ion pump; 4-Acetamido-4'-isotkiocyanatostilbeae.2,2'-disulfonic acid (SITS) 
1. INTRODUCTION 
Stilbenes, like SITS (4-acetamido-4'-isothiocyana- 
tostilbene-2,2'-disulfonic a id) and the related com- 
pound H~_DIDS (dihydro-4,4'-diisothiocyanatostilbene- 
2,2'-disulfonate), have been shown to inhibit the Na,K- 
ATPase found in the basolateral membrane ofjejtmum 
[1] and rat brain microsomes [2]. We have reported [3-6] 
that H~.DIDS irreversibly inhibited the pNPPase and 
Na,K-ATPase activities of canine renal enzyme. Inacti- 
vation occurs alter formation of an inhibitory reversible 
complex. The reversible inhibition was not affected by 
Na pump ligands, whereas the irreversible inactivation 
was prevented by either ATP or K. The inactivation by 
H_,DIDS could have been produced by intramolecular 
cross-linking, as has been observed with Band 3 [7]. To 
avoid this potential complication, we have utilized 
SITS, which cannot form cross-links as it has only one 
isothiocyanate group. We show here that SITS inacti- 
vates the Na,K-ATPase by covalent reaction with Lys- 
501, which has been shown to be the site of modification 
of other amino-reactive reagents whose effects are pre- 
vented by the simultaneous presence of ATP. 
2. EXPERIMENTAL 
2.1, Materials 
TPCK-treated trypsin was from Worthington. Dithiothreitol 
(DTT), SDS, urea and the Bio-Sil TSK size exclusion columns were 
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from Bio-Rad Laboratories; iodoacetamide (IAM) and SITS were 
from Sigma Chemical Co. All buffer salts and HPLC grade acetoni- 
trile were obtained from Fisher Scientific. The 300 A pore size CI8 
(218-TP-5415) and C4 {214-TP-5415~ reverie-phase columns ~'~ere 
from the Sep~trations Group (Vyduc). A LDC-Milton Roy HPLC 
system was used as described previously [12]. Peptides were sequenc~xl 
on a Porton 2090E gas phase sequenator. The amino acid analyses and 
protein sequences were determin~.xl by the Protein Core Facility of the 
Department of Pharmacology and Cell Bioph),sies of the University 
of Cincinnati. 
The Na,K-ATPase was purified from dog kidneys and assayed as 
described previously [6], Na,K-ATPase used in these studies had a 
sp,-'eific activity of about 20/~mol of P, liberated/mg/min. 
2,2, lnactiration oJ'the Na, K.ATPase b)' SITS 
Tile enzyme (I big) wa~ incubated at 37°C in a medium (30 brl) 
containing (in raM): Tris-HCl 50 (pH 9.2); EDTA 1; with the concen- 
trations of I-I.DIDS and SITS indicated in Fig. I. After 60 rain. 20/fl 
of a mixture containing 0,75 m~ml bovine serum albumin and 125 
mM 2-mercal~toethanol was added. The total volume was diluted to 
600/~1 with the assay mixture and the Na,K-ATPase activity deter- 
mined, These conditions are sufficient o eliminate all non-reacted 
SITS, to stop further eaction, arid to prevent the reversible inhibition 
during enzyme assay, 
2.3. Pr,,paretion oj SITS-lahd,'d eao'nte 
The enzyme (3 rag) was incubated at 37°C in a medium (50 mlj 
containing froM): Tris-HC150 (pH 9.2); EDTA 1; and SITS 0.012. The 
m~.xtium alao contained 0.5 mM PIMSF and 1/.tg/ml aprotinin. Sample~ 
containing eithe." KCI (0.1 raM). or ADP (3 raM), or no inhibitor, were 
prepared in parallel. The concentration f SITS was calculated from 
its absorbance spectrum using a molar extinction coefl]cient of 40 
mM -~ , em -~ at 336 am. The spectrum of the SITS solution was 
determined I:mfore ach use to determine reagent concentration a d 
inte,~rity. After treatment, an aliquot of each sample was used to 
determine the remaining Na,K-ATPas¢ activity. The samph.~ were 
centriftlged 430,000 × g l'or 10 rain, the supernatants di carded, and 
the pellets were resus.nend~l with I ml of 0.5 M EDTA-Tris. pH 6,9. 
Samples were centrifug~ at430,090 ×,~ for 20 rain and the pellets were 
resuslxnded with I ml of 109 mM EDTA-Tris, 0.5% 2-mereaptoetha- 
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nol, pH 7, containing 1 M KCI. After 1 h at room temperature, the 
samples were washed by centrifugution and resuspetasion with water. 
2.4. Proreolysis ~!I the SITS-tabeled pcotein, pur([k'athm and seque¢we 
attatyst.~" 
The pelleted Na,K-ATPase samples (inactivated and protected) 
were homogenized with 150 pl water and solubilized with 200 ~tl of 
20% SDS. The solubilized protein was alkylated with 100 mM io- 
doacetamide (IAM) in 200 mM Tris-HCl, pH 8.3. at 37°C for 15 rain. 
The ¢-subunit was isolated by ItPLC usin~ a size-exclusion column 
(Bio-Sil TSK250) equilibrated with 50 mM NaFI:PO~, pH 5.77, con- 
mining 0.1% SDS and 0.01% NaN~ [8]. The absorbance of the eluent 
was monitored at 280 nm and the ",.subanit was collected. The solu- 
tion was concentrated to 100 pl using Centricon-30 devices, treated 
with 20 mM DTT for 30 rain at 60°C, and realkylated as before. The 
samples were then reinjected onto the HPLC column to remove xcess 
reagents. Allquots of the repurified =-subunit were withdrawn for 
amino acid analysis. The purified 'r-subunit was concentrated in a 
Centrieon-30 to 250 pl, and the protein was precipitated by the addi- 
tion o1"4 vols. o f -20°C acetone followed by incubation in dry-ice and 
ethanol for I h. The precipitated protein was pelleted by cent rifugation 
and the superlaatant removed. 100 ~1 o1"8 M urea was added and the 
pellet dislodged from the side of the tube and then sonieated for 10 
mln. Then, 80pl ol'500 mM NH4HCO~, pH 8.3, 200 itl of H,O, and 
I0/~1 of 2 m~ml of trypsin in 1 mM HCI were added, and the sample 
was incubated at 37°C for 2 h with occasional mixing. The ratio of 
trypsin to ~-subunit was approximately 1:50. A second 10 ,ttl aliquot 
of trypsin was added to the sample, and the digestion was cominued 
overnight. The peptide digest was injected onto a HPLC C 18 column 
and the peptides were separated using a linear ~radient of 10-40% 
CH.~CN in water containing 0.1% TFA over 30 rain. The peptides were 
monitored at 333 nm. which was the wavelength of maximum absorp- 
tion for SITS in 0.1% TFA/H,O. The SITS-labeled peptides were 
repurified on a C4 column using a linear gradient of 15-20% CH.~CN 
containing 0.1% TFA over 30 rain. 
3. RESULTS 
Both SITS and 
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Fig. 1. Inactivation of the N~,g-ATPa~ by H,DIDS and SITS. The 
reaction was performed as described in scctlor, 2. The apparent first 
order reaction constants were calculated using the formula log t,Jv,, = 
k: f .  t/2.3 k~ where v~ and vo are the reaction velocities in the absence 
and presence of the inhibitor, L indicates the concentration of inhibi- 
tor, and t the time of treatment. The formula was calculated assuming 
the following reaction: 
E + 1 ~ (ED -~ Ei and k' = ktl/Ki, 
h '  i k I 
as previously described [18]. 
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Fig. 2. Peptide mapping of the SITS-labeled =-subunit. After trypsin 
treatment of 3 mg of SITS-labeled Na,K-ATPase, the fragments pro- 
duced were separated by HPLC as indicated in section 2. The chroma- 
tograms are of the tryptic fragments from the inactivated control- 
(top), the K-protected- (middle), and the ADP.protected (bottom) 
N a, K-ATPase samples obtained by C18 H PLC. The peaks labeled 15 
and 17 were repurified and sequenced (see Table 1). 
Na,K-ATPase (Fig. 1). The enzyme was incubated with 
different concentrations of either SITS or H:DIDS, and 
assayed after 30 rain. As previously described for 
H:DIDS [5], the inactivation by SITS was protectable 
by either ADP or K. The remaining Na,K-ATPase ac- 
tivity was 100% and 88% with K (0.1 raM) and ADP (3 
mM), respectively, when the protein was incubated for 
1 h with 12 ~tM SITS, as compared with the activity 
remaining in the treated control• After labeling, the 
Na,K-ATPase subunits were separated by SDS-PAGE. 
As previously observed with H2DIDS [5]~ SITS appears 
to label only the g-subtmit (data not shown). 
ADP-protected-, K-protected- and SITS-inactivated 
samples of the Na,K-ATPase were solubilized with SDS 
and processed as described above (see section 2). Fig. 2 
shows chromatograms of the SITS-labeled proteolytic 
fragments of the inactivated enzyme, and those corre- 
sponding to the K- and ADP-protected samples. The 
apparent absorbance in the void volume (approximate 
retention time of 3 rain) is due to refractive index effects 
caused by urea. Most of the SITS bound to the protein 
was contained in several peaks which were observed in 
much smaller amounts in the K- or ADP-protected 
samples. The two major peaks of  SITS-labeled peptides 
(peaks 15 and 17 in Fig. 2) were further purified on a 
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C4 column using a linear gradient of 15-20% CH~CN 
containing 0.1% TFA over 30 rain, and sequenced. 
Table I shows the amino acids detected in each cycle 
and the corresponding recovery. The sequence deter- 
mined corresponds to the sequence that starts at His- 
496 in the cx-subunit of the sheep kidney Na,K-ATPase 
[9] ((the dog kidney 0~-subunit sequence has not been 
published). The residue at position 501 corresponding 
to a Lys in the eDNA sequence of lamb kidney Na,K- 
ATPase was not detected, indicating that this is the 
amino acid modified by SITS. The reason for the differ- 
ent elution positions in the C18 column chromatogra- 
play of peptides 15 and 17 is not clear, since they yielded 
the same amino acid sequence and the same site of 
labeling. 
4. DISCUSSION 
The sequence of the peptide fi'agments labeled by 
SITS indicated that the binding of the probe was to 
Lys-501 on the ~x-subunit of Na,K-ATPase. The two 
major peptides equenced account for most of the SITS 
labeling (see Fig. 2, top panel). A repeat of the entire 
labeling/purification/sequencing scheme gave identical 
results (data not shown). There were other minor peaks 
labeled, and their labeling was prevented by K or ADP, 
but they were not sequenced. The SITS labeling was 
specific and it was nearly abolished by the presence of 
ADP (an ATP analog) or K, both of which are ligands 
of the enzyme. The fact that these two ligands affected 
the inactivation suggests that the region around the 
labeled amino acid (Lys-501) may be involved in or is 
Sequence data fi'om the 
Table I 
SITS-labeled peptides isolated from the ,v. 
sabunit 
Cycle Peak 17 Peak 15 
Amino acid lamoi Arnino acid pmol 
(residue no.) (r,'sidue no.) 
1 His (496) 14 His (496) 7 
2 Leu (497) 36 Lcu (497) 8 
3 Leu (498) 38 Lcu (498) 7 
4 Val (499) 42 Val (499) 9 
5 Met (500) 28 Met (500) 6 
6 X X 
7 Gly (502) 16 Gly (502) 4 
8 Ala (503) 21 Ala (503) 4 
9 Pro (504) l0 Pro (504) 3 
10 GIn (505) 10 GIn (505) 2 
l I Arc Arc 
Amino acids in cycles 6 and 11 were not identified, and they corre- 
spond to L)'s and Ar 8, respectively, in the published sequence of the 
sheep kidney 1Na,K-ATPase ct.subunit [9]. Peptidc C-terminal Arc 
residues are very often not detected in protein sequencing. No other 
amino acids were present in several sequencer cycles alter 11 on either 
salr~ple, consistent with the prusumed trypsil; cleavage at the unde- 
tected Arc residue. 
modified by conlbmaational changes associated with 
the binding of these ligands. It is not yet clear why SITS 
apparently covalently modifies Lys-501, while prelimi- 
nary data suggests that H:DIDS is attached to a lysine 
residue closer to the carboxyl-terminus [10]. 
Lys-501 has been shown to be labeled by FITC (fluo- 
rescein isothiocyanate) which also inactivates the Na°K- 
ATPase [11,12] and also by NIPI (N-(2-nitro-4-isothio- 
cyanophenyl)-imidazole) [13,14]. SITS, FITC, and 
NIPI are all aryl isothioeyanates. The different extents 
to which K ions protect against NIPI and SITS inactiva- 
tion probably has a kinetic basis and depends upon the 
relative reactivlties of Lys-501 with these reagents. The 
fact that labeling and inactivation of the Na,K-ATPas¢ 
by these probes can be prevented by ATP supports the 
hypothesis that they bind to the nucleotide binding site. 
However, recent experimental evidence has cast doubt 
on the idea that Lys-501 is an essential part of the ATP 
site. For example, antibodies which specifically bind to 
the segment hat includes Lys-501 failed to inhibit 
Na,K-ATPase activity [i 5]. Site-directed mutagenesis of 
the corresponding FITC-reactive Lys to Giu in the sar- 
coplaslrfiC reticulum Ca-~+-ATPase resulted in only a 5% 
decrease in Ca "-+ transport [16], and more recent analy- 
sis of Ca 2+ pump mutants uggests that this lysine resi- 
due is not essential for ATP binding [17]. These data 
indicate that Lys-501 and its amino group may not be 
essential for activity° but that the binding of chemical 
probes to Lys-501 may inhibit the enzyme activity by 
interfering with neighboring amino acids, by filling a 
space necessary for the binding/hydrolysis of ATP or 
disturbing conformationai changes associated with the 
enzymatic cycle of the protein. 
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